Summit Therapeutics Inc

Organisation

601 Brickell Key Drive, Miami, FL, United States, 33131

Headquarters

Employees

Health Technology

Industry

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

Price

Target

Summit Therapeutics Inc (SMMT) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Summit Therapeutics Inc (SMMT) share price will touch around $29.34 in next 12-months.

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $29.34. This median of share price forecast represents a 88.08% upside from the latest price of $15.6 as on 20.03.26.

Summit Therapeutics Inc (SMMT) Share Price Forecast

Home

US Stocks

Summit Therapeutics Inc (SMMT)

Summit Therapeutics Inc Stock Forecast

Summit Therapeutics Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Summit Therapeutics Inc (SMMT): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 20.03.26, the difference is -47.57%

Summit Therapeutics Inc Forecast and Target Price

Summit Therapeutics Inc (SMMT) Share Price Forecast

Summit Therapeutics Inc (SMMT) Price vs Consensus Price Target

Summit Therapeutics Inc (SMMT) Share Price Forecast v/s Share Price Today

Summit Therapeutics Inc (SMMT): Difference between Current Price & Median Forecasted Price

Summit Therapeutics Inc (SMMT) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price